CPRIT leaders enjoy campus tour showcasing cancer research initiatives and capabilities
Senior officials from the Cancer Prevention and Research Institute of Texas visited Rice Nov.11 for a firsthand, comprehensive look at the university’s cancer-focused collaborative research initiatives and innovation-driven facilities and labs.
The Educational and Research Initiatives for Collaborative Health (ENRICH) at Rice University and The Bookout Center at Houston Methodist hosted the first joint faculty engagement event aimed at fostering collaboration between researchers at the two institutions.
Cancer Bioengineering Collaborative hosts kickoff event, awards first round of seed grants
Leaders and researchers from Rice and the University of Texas MD Anderson Cancer Center came together this month to celebrate the launch of the Cancer Bioengineering Collaborative, first announced earlier this summer.
Rice has launched RBL LLC, a pioneering biotech venture creation studio designed to rapidly build companies based on lifesaving medical technologies developed out of the Rice Biotech Launch Pad.
Research institute representative highlights Texas’ collaborative efforts with Rice in cancer battle
Abria Magee, senior program manager for the Cancer Prevention and Research Institute of Texas, gave an overview of the agency’s efforts to fuel innovation in cancer research and drive advancements in prevention and cures at the recent AI in Health Conference hosted by Rice’s Ken Kennedy Institute.
Rice is part of multiuniversity research team that has secured $34.9 million from ARPA-H to accelerate the development of a bioelectronic implant designed to revolutionize treatment for obesity and Type 2 diabetes, improving patient experience and outcomes while reducing the development and manufacturing costs.
Ken Kennedy Institute’s annual conference informs the future of AI in health innovation
Rice’s Ken Kennedy Institute hosted the third annual AI in Health Conference Sept. 9-12, welcoming over 470 participants to Houston to explore the latest advancements in artificial intelligence.
Rice student team takes top prize in national competition with innovative medical device
A team of Rice engineering students was awarded the top prize in a prestigious national design competition for its innovative medical device for urological care.
Rice and Baylor College of Medicine have received $2.8 million from the NIH for research on reducing inflammation and lung damage in acute respiratory distress syndrome patients.
Rice and MD Anderson launch initiative to advance cancer-focused operations research
Rice and The University of Texas MD Anderson Cancer Center today announced the launch of the Center for Operations Research in Cancer, a joint initiative to solve complex challenges in cancer care using data science to make better operational decisions.
Annual Rice event explores AI innovation in health care
Rice’s Ken Kennedy Institute is hosting the third annual AI in Health Conference Sept. 9-12 with themes this year including foundation models in medicine, LLM applications, AI in neuroscience and neurotechnology, digital twins in health care and patient engagement and equity in health AI.
Rice and MD Anderson launch Cancer Bioengineering Collaborative
Rice and the University of Texas MD Anderson Cancer Center today announced the creation of the Cancer Bioengineering Collaborative to develop innovative technologies and bioengineering approaches to improve cancer research, diagnosis and treatment.
Rice, Baylor College of Medicine centers jointly award seed grants
Rice University’s Synthesis X Center (SynthX) and Baylor College of Medicine’s Dan L Duncan Comprehensive Cancer Center have jointly awarded their first innovation seed grants to three teams of research collaborators from Rice and Baylor.
Rice student making a difference in community through lung cancer research
Priyanka Senthil is maximizing her opportunities at Rice through her research and advocacy work related to lung cancer screening.
Rice’s new Synthesis X Center has winning formula for cancer innovation
Rice has created the new Synthesis X Center to bring together clinicians treating cancer and researchers looking for cures to help spur drug discovery make precision adjustments to drug properties and translate fundamental research discoveries into clinical applications.
